Form No. E - Quarterly return of manufacture of controlled substance in Schedule-A - See sub-clause (6) of clause 4 - Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013
Contents
Rules & Regulations
Summary
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Quarterly controlled-substance reporting requires separate stock, manufacture and sale returns, certified records, and disclosure of delayed filing fines. Quarterly Form E returns for each Schedule-A controlled substance must record the manufacturer's identification, opening and closing stock, and details of ... Summary
Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013
Quarterly controlled-substance reporting requires separate stock, manufacture and sale returns, certified records, and disclosure of delayed filing fines.
Quarterly Form E returns for each Schedule-A controlled substance must record the manufacturer's identification, opening and closing stock, and details of manufacture and sale. Sale entries include purchaser particulars and consignment note details, with quantities stated in kilograms. The return must disclose timely or delayed filing, including any fine paid, be certified as correct with supporting records available, and be sent to the concerned Zonal Director of the Narcotics Control Bureau. Import or export entries require No Objection Certificate particulars.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.